Fredun Pharmaceuticals Share Price
1524.50+36.30 (+2.44%)
+265.85% past 1 Year
Fredun Pharmaceuticals Limited is engaged in manufacturing of pharmaceutical products. The company is trusted by customers across Africa, Southeast Asia, Commonwealth of Independent States (CIS) countries and Latin America. The
Corporate filings & documents
Announcements
Intimation regarding permission to trade and admission of Equity Shares to dealing on the National Stock Exchange of India
2 weeks agoIntimation regarding permission to trade and admission of Equity Shares to dealing on the National Stock Exchange of India
2 weeks agoTranscript of the Earnings Conference call held on 13th August 2026 for Q1 FY27.
2 weeks agoTranscript of the Earnings Conference call held on 13th August 2026 for Q1 FY27.
2 weeks agoStatement of Deviation or Variation For the Quarter Ended June 30 2026.
2 weeks agoStatement of Deviation or Variation For the Quarter Ended June 30 2026.
2 weeks agoMonitoring Agency Report dated 14.08.2026
2 weeks agoMonitoring Agency Report dated 14.08.2026
2 weeks agoAudio Recording Q1 FY27 Earnings Conference Call of FredunPharmaceuticals Limited.
3 weeks agoAudio Recording Q1 FY27 Earnings Conference Call of FredunPharmaceuticals Limited.
3 weeks agoIntimation of Earnings Conference Call for the quarter Q1 of FY27.
3 weeks agoIntimation of Earnings Conference Call for the quarter Q1 of FY27.
3 weeks agoNewspaper Advertisement of the Un-Audited Financial Results for Quarter ended 30th June 2026
4 weeks agoNewspaper Advertisement of the Un-Audited Financial Results for Quarter ended 30th June 2026
4 weeks agoNewspaper Advertisement of the Un-Audited Financial Results for Quarter ended 30th June 2026
4 weeks agoNewspaper Advertisement of the Un-Audited Financial Results for Quarter ended 30th June 2026
4 weeks agoPress Release issued by Fredun Pharmaceuticals Limited
4 weeks agoPress Release issued by Fredun Pharmaceuticals Limited
4 weeks agoOutcome of the Board Meeting
1 month agoOutcome of the Board Meeting
1 month agoIn compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Un-Audited Financial Results of the Company for the quarter ended 30th June 2026 along with the Limited Review Report as issued by M/s. R.H. Nisar & Co Statutory Auditor of the Company
1 month agoIn compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Un-Audited Financial Results of the Company for the quarter ended 30th June 2026 along with the Limited Review Report as issued by M/s. R.H. Nisar & Co Statutory Auditor of the Company
1 month agoFredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that a meeting of the Board of Directors of Fredun Pharmaceuticals Limited is scheduled to be held on Wednesday 05th August 2026 inter-alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the first quarter ended 30th June 2026.
1 month agoFredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that a meeting of the Board of Directors of Fredun Pharmaceuticals Limited is scheduled to be held on Wednesday 05th August 2026 inter-alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the first quarter ended 30th June 2026.
1 month agoAllotment of Bonus Equity Shares.
1 month agoAllotment of Bonus Equity Shares.
1 month agoIntimation of Record Date pursuant to SEBI LODR Regulations 2015 for Issue of Bonus Equity Shares.
1 month agoIntimation of Record Date pursuant to SEBI LODR Regulations 2015 for Issue of Bonus Equity Shares.
1 month agoCertificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018
1 month agoCertificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018
1 month agoScrutinizers Report for 39th Annual General Meeting.
2 months agoScrutinizers Report for 39th Annual General Meeting.
2 months agoOutcome of 39th Annual General Meeting
2 months agoOutcome of 39th Annual General Meeting
2 months agoIntimation of Closure of Trading Window
2 months agoIntimation of Closure of Trading Window
2 months agoTranscript of the Earnings conference call held on 10th June 2026 for Q4 FY26.
2 months agoTranscript of the Earnings conference call held on 10th June 2026 for Q4 FY26.
2 months agoAudio Recording of the Q4 and year ended for the FY26 Earnings Conference Call
2 months agoNewspaper Clipping- Information regarding 39th Annual General Meeting to be held on 30th June 2026 through video conference/other audio visual means.
2 months agoNewspaper Clipping- Information regarding 39th Annual General Meeting to be held on 30th June 2026 through video conference/other audio visual means.
2 months agoIntimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations")
2 months agoIntimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations")
2 months agoIntimation of Record Date for the purpose of Final Dividend for the Financial Year 2025-26
2 months agoIntimation of Record Date for the purpose of Final Dividend for the Financial Year 2025-26
2 months agoNotice of Book Closure for the purpose of 39th Annual General Meeting (AGM)
2 months agoNotice convening 39th Annual General Meeting ("AGM") of Fredun Pharmaceuticals Limited
2 months agoAnnual Report of Fredun Pharmaceuticals Limited for the Financial Year 2025-2026 including the Notice of the 39th Annual General Meeting of the Company scheduled to be held on Tuesday 30th June 2026 at 09:00 a.m. through Video Conference (VC) / Other Audio Visual Means (OAVM).
2 months agoAnnual Report of Fredun Pharmaceuticals Limited for the Financial Year 2025-2026 including the Notice of the 39th Annual General Meeting of the Company scheduled to be held on Tuesday 30th June 2026 at 09:00 a.m. through Video Conference (VC) / Other Audio Visual Means (OAVM).
2 months agoRevised intimation of Earnings Conference Call for the quarter Q4 of FY26.
2 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Jun 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
Jan 2023
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-07-16
Bonus
2:1
2026-06-23
Dividend
0.7
2025-09-23
Dividend
0.7
2024-09-23
Dividend
0.7
2023-09-22
Dividend
0.7
Company details
Registered office
11th Floor, Tower A Urmi Estate 95, Ganpatrao Kadam Marg Lower Parel (West) Mumbai Maharashtra PIN: 400013 Tel No: 022-40318111 Fax No: 022-40318133 Email: [email protected] Internet: www.fredungroup.com
Registrars
Gala No 9, Shiv Shakti, Industrial EstateSitaram Mill Compound, J R Boricha Marg Gala No 9 Shiv Shakti, Industrial Estate,Sitaram Mill Comp. J R Boricha Marg, Lower Parel [E] PIN: Tel No: +91 22 4134 3255/ +91 22 4134 3256 Fax No: NULL Email: [email protected] Internet: www.purvashare.com
Management
Daulat Medhora, Chairperson & Joint Managing Director
Daulat Medhora, Chairperson & Joint Managing Director
Fredun Medhora, Managing Director & Chief Financial Officer
Pooja Narendra Sanghavi, Non Executive Independent Director
Anshu Agarwal, Non Executive Independent Director
Sonal Dharmin Desai, Non Executive Independent Director
Daisy Cyril Dsouz, Non Executive Independent Director
Details
BSE 539730
NSE FREDUN
ISIN INE194R01017